SAVA
Cassava Sciences, Inc. Healthcare - Neuroscience Investor Relations →
Cassava Sciences, Inc. (SAVA) closed at $1.82 as of 2026-03-20, trading 89.4% below its 200-week moving average of $17.17. This places SAVA in the extreme value zone. The stock is currently moving closer to the line, down from -88.5% last week. With a 14-week RSI of 23, SAVA is in oversold territory.
Trading volume is running at 0.6x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.79 ratio) is neutral — neither side is clearly dominating.
Over the past 1292 weeks of data, SAVA has crossed below its 200-week moving average 25 times. On average, these episodes lasted 36 weeks. Historically, investors who bought SAVA at the start of these episodes saw an average one-year return of +122.3%.
With a market cap of $115 million, SAVA is a small-cap stock. The company generates a free cash flow yield of 16.1%, which is notably high. Return on equity stands at -85.4%. The stock trades at 1.4x book value.
Share count has increased 15.7% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 24.8 years, a hypothetical investment of $100 in SAVA would have grown to $6, compared to $831 for the S&P 500. SAVA has returned -10.8% annualized vs 8.9% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 6 open-market purchases totaling $1,231,784. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while SAVA is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: SAVA vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After SAVA Crosses Below the Line?
Across 25 historical episodes, buying SAVA when it crossed below its 200-week moving average produced an average return of +151.3% after 12 months (median +6.0%), compared to +7.8% for the S&P 500 over the same periods. 56% of those episodes were profitable after one year. After 24 months, the average return was +65.5% vs +21.4% for the index.
Each line shows $100 invested at the moment SAVA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
SAVA has crossed below its 200-week MA 25 times with an average 1-year return of +122.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 2001 | Jan 2004 | 133 | 80.8% | -10.7% | -94.4% |
| Jan 2004 | May 2004 | 18 | 25.9% | -9.3% | -94.3% |
| Jul 2004 | Aug 2004 | 8 | 18.3% | -18.9% | -94.3% |
| Sep 2004 | Nov 2004 | 6 | 5.8% | -8.6% | -93.7% |
| Jan 2005 | Jan 2005 | 3 | 3.1% | +5.7% | -93.3% |
| Feb 2005 | Sep 2005 | 30 | 27.9% | +53.0% | -93.3% |
| Sep 2005 | Nov 2005 | 7 | 11.3% | +25.7% | -93.2% |
| Mar 2007 | Mar 2007 | 3 | 1.9% | +7.3% | -93.9% |
| Mar 2008 | Mar 2008 | 1 | 2.3% | -51.0% | -94.3% |
| Mar 2008 | May 2008 | 9 | 13.1% | -45.6% | -94.4% |
| Jun 2008 | Jul 2008 | 6 | 8.3% | -27.7% | -94.1% |
| Nov 2008 | Nov 2008 | 1 | 8.8% | -36.4% | -94.0% |
| Dec 2008 | Oct 2010 | 98 | 53.2% | -18.3% | -93.0% |
| Dec 2010 | Dec 2010 | 1 | 7.1% | -25.0% | -93.3% |
| Jun 2011 | Sep 2012 | 66 | 32.9% | -8.5% | -93.6% |
| Oct 2012 | Mar 2013 | 19 | 48.4% | +58.4% | -88.8% |
| Mar 2013 | Oct 2013 | 30 | 39.0% | +63.3% | -92.4% |
| Sep 2014 | Sep 2014 | 1 | 2.1% | -51.6% | -93.2% |
| Oct 2014 | Oct 2014 | 1 | 0.2% | -48.4% | -93.3% |
| Oct 2014 | Dec 2019 | 270 | 90.5% | +6.3% | -85.1% |
| Mar 2020 | Mar 2020 | 3 | 20.3% | +1193.9% | -56.1% |
| May 2020 | Sep 2020 | 18 | 52.6% | +1830.2% | -14.4% |
| Apr 2022 | May 2022 | 4 | 4.7% | +23.6% | -90.5% |
| Jul 2022 | Aug 2022 | 3 | 24.1% | +28.5% | -88.9% |
| Feb 2023 | Ongoing | 161+ | 95.7% | Ongoing | -92.7% |
| Average | 36 | — | +122.3% | — |
Frequently Asked Questions
Is SAVA below its 200-week moving average?
Yes. As of 2026-03-20, Cassava Sciences, Inc. (SAVA) is trading 89.4% below its 200-week moving average of $17.17. The current price is $1.82.
What is SAVA's 200-week moving average price?
Cassava Sciences, Inc.'s 200-week moving average is $17.17 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when SAVA drops below its 200-week moving average?
SAVA has crossed below its 200-week moving average 25 times in our data. On average, buying at that moment produced a one-year return of +122.3%. These dips have historically been decent entry points. These episodes lasted 36 weeks on average.
Is SAVA a good value right now?
Here's what our data says about SAVA as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 23 (oversold). Free cash flow yield is 16.1%. Return on equity is -85.4%. Price-to-book is 1.4x. This is not a buy or sell recommendation — always do your own research.
How does SAVA compare to the S&P 500?
Over the past 24.8 years, $100 invested in SAVA would have grown to $6, compared to $831 for the S&P 500. That's -10.8% annualized vs 8.9% for the index. SAVA has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20